Swine flu ppt


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • While there are three types of influenza viruses—A, B, and C—only two cause significant disease in humans (A and B). Type B influenza viruses are limited to humans, whereas Type A viruses can cause severe disease in humans and affect more species. Influenza Type A Type A influenza is considered to cause the most serious disease among the influenza viruses, although not all strains cause clinical disease. Influenza A can cause severe epidemics (as well as severe worldwide epidemics; or pandemics) among all ages. Influenza type A infects multiple species including people, birds, pigs, horses, and other animals. Wild birds are the natural hosts for these viruses. Influenza Type B Influenza B viruses are usually found only in humans. Influenza B viruses can cause some morbidity and mortality among humans, but in general are associated with less severe epidemics (chiefly among children) than influenza A viruses. Although influenza type B viruses can cause human epidemics, they have not caused pandemics. Because avian influenza and all pandemic viruses are of the Type A variety, we will focus this session on Type A influenza viruses.
  • While seasonal influenza occurs every year, pandemic influenza rarely occurs. Here we compare some features of seasonal influenza with features of pandemic influenza. While the population usually has some immunity built up from previous exposures to seasonal influenza, the human population lacks any immunity to pandemic influenza strains. In seasonal influenza epidemics, infants and the elderly are most at risk of illness and complications. But during an influenza pandemic, even healthy, young people are at increased risk for serious complications. Seasonal influenza strains are the result of Antigenic Drift, while pandemic influenza strains are the result of Antigenic Shift.
  • 2 of the 3 prerequisites for a human pandemic have been met A novel influenza virus has emerged and the general population has demonstrated little or no immunity And the new virus has been able to replicate in humans The main questions that remains are: Will the virus will develop into a form that is efficiently transmitted from one human to another? (thus meeting the criteria for a pandemic) If so, where, when, how quickly, and how severely? The first two of three prerequisites have been met: A novel virus Virus must be able to replicate in humans and cause disease New virus must be efficiently transmitted from one human to another Virus can improve its transmissibility via two mechanisms: adaptive mutation genetic reassortment (can take place in humans without prior adaptation in another mammalian species, such as the pig)
  • It can be difficult to tell if a patient has influenza because the signs and symptoms for influenza are similar to those for other diseases that may cause respiratory illnesses. If you do suspect influenza, there are a few differences between human influenza and avian influenza that you can assess, especially in the early days of illness. Human influenza usually causes both upper respiratory (sore throat runny nose) and lower respiratory (cough, bronchitis) symptoms. Common signs and symptoms include fever, headache, cough, sore throat, muscle ache, and exhaustion. Other respiratory symptoms may appear, varying from sore throat to difficulty breathing. Children and the elderly may also have gastrointestinal symptoms like diarrhea, vomiting and nausea, but adults uncommonly have gastrointestinal symptoms, except loss of apetitie. People generally recover anywhere from 2 to 7 days after symptoms appear. However, cough and muscle ache may last more than 14 days. Although influenza generally causes an upper respiratory infection with tracheobronchitis, it can progress to pneumonia and respiratory failure in some cases. Although similar initially, avian influenza differs from human influenza in its course. Avian influenza leads to a lower respiratory illness with variable upper respiratory involvement. Initial symptoms are similar to human influenza. These include fever, headache, cough, sore throat, muscle ache, and exhaustion. Gastrointestinal symptoms of watery diarrhea, vomiting, and abdominal pain have been more commonly reported from H5N1 patients (20-70% diarrhea rate depending on case series). Symptoms of a lower respiratory infection appear early in course of the illness. About five days after symptoms appear, patients often begin to have difficulty breathing leading to respiratory distress, and an increased respiratory rate may also be observed. By this time, cough is prominent, sputum production may occur sometimes containing blood. Most patients develop pneumonia with bilateral pulmonary infiltrates. Ref: Writing Committee on WHO Consultation. NEJM 353:1374-85, 2005
  • We have just discussed infection control measures in health care facilities to prevent patient to health care worker and patient to patient transmission of avian influenza. Next we will discuss how to prevent person to person spread of avian influenza in the community. Specific infection control policies and procedures may be easier to implement in a controlled environment such as a medical facility, but good infection control practices can also be adapted to prevent and control respiratory disease transmission in the community. The following measures to contain respiratory secretions are recommended for all individuals with symptoms of a respiratory infection such as avian influenza: -Cover the nose and mouth with a mask, tissue or cloth when coughing or sneezing, and dispose of the tissue in the nearest waste receptacle after use. -If a mask, tissues or cloth are not available, cough or sneeze into your upper sleeve versus your hands. -Perform hand hygiene (e.g., hand washing with non-antimicrobial soap and water, alcohol-based hand rub, or antiseptic hand wash) after having contact with respiratory secretions or contaminated objects. (NOTE TO REVIEWERS: PLEASE ADD IN USE OF LOCAL MATERIALS HERE)
  • While not formally a type of PPE, we will first discuss hand hygiene, because it is the cornerstone of infection control! Always remember to wash hands in between contact with each new patient. This slide describes effective hand hygiene techniques: When washing hands with soap and water, first wet hands with water, then apply the amount of soap recommended by the manufacturer. Rub hands together for at least 20 seconds, covering all surfaces of the hands and fingers. Rinse hands with water, dry them thoroughly with a disposable towel, and use the towel to turn off the faucet. Of course, this assumes that clean water is available. If there is any doubt about this, boiled or bottled water, or water treated with chlorine tablets should be used. *Source: Guideline for Hand Hygiene in Health-care Settings. MMWR 2002; vol. 51, no. RR-16.
  • If hands are not visibly soiled, alcohol-based hand cleaners are also effective. When decontaminating hands with an alcohol-based hand rub, apply product to palm of one hand and rub hands together, covering all surfaces of hands and fingers, until hands are dry. The volume to use depends on the manufacturer directions, but usually a coin-sized amount in your hand is sufficient.
  • As with any infectious disease, there is the potential for avian influenza to be transmitted in the home. Therefore, people within the home of an infected individual should be educated on the risk for transmission, and ideally wear personal protective equipment including gloves, gowns and surgical masks. If PPE items are unavailable, readily available materials such as tissues or cloths should be used. And hand hygiene, as always, is critically important in preventing the spread of avian influenza in the home. Finally, as will be discussed in a moment, anyone handling corpses should wear protective gear.
  • Swine flu ppt

    1. 1. Swine flu By Dr Anil Barkul, MD(Med),DTCD
    2. 2. 2 Influenza Virus Types A and B Type A (Seasonal, avian, swine influenza,….) Type B (Seasonal influenza) Can cause significant disease Generally causes milder disease but may also cause severe disease Infects humans and other species (e.g., birds; H5N1) Limited to humans Can cause epidemics and pandemics (worldwide epidemics) Generally causes milder epidemics
    3. 3. 1920 1940 1960 1980 2000 H1N1 H2N2 H3N2 1918: "Spanish Flu" 1957: "Asian Flu" 1968: "Hong Kong Flu" 20-40 million deaths 1-4 million deaths 1-4 million deaths
    4. 4. Pandemic Waves (1918-1919)
    5. 5. Seasonal Influenza – A public health problem each year – Usually some immunity built up from previous exposures to the same subtype – Infants and elderly most at risk Influenza Pandemics – Appear in the human population rarely and unpredictably – Human population lacks any immunity – All age groups, including healthy young adults Seasonal Epidemics vs. Pandemics
    6. 6. The new virus must beThe new virus must be efficientlyefficiently transmitted from one human to anothertransmitted from one human to another The new virus must beThe new virus must be efficientlyefficiently transmitted from one human to anothertransmitted from one human to another Prerequisites for pandemic influenza A new influenza virus emerges to which the general population has little/no immunity The new virus must be able to replicate in humans and cause disease
    7. 7. TheThe InfluenzaVirusInfluenzaVirus
    8. 8. A H1N1 :new virus • The 2009 H1N1 virus is a hybrid of swine, avian and human strains Influenza A (H1N1)
    9. 9. Viral Re-assortment Reassortment in pigs Reassortment in humans Pandemic Influenza Virus
    10. 10. WHO Pandemic PhasesWHO Pandemic Phases
    11. 11. Big droplets fall on people surfaces bed clothes Courtesy of CDC
    12. 12. Signs and Symptoms Human Influenza Type of infection Upper and lower respiratory Fever Yes Headache Yes Cough Yes Respiratory symptoms Varies; sore throat to difficulty breathing Gastrointestinal symptoms Uncommon, except children, elderly Recovery 2-7 days
    13. 13. Swine flu • "The entire purpose is to limit exposure" • The Centers for Disease Control and Prevention hopes to have a vaccine to manufacturers within 6 months (??)
    14. 14. Non-pharmaceutical Interventions 1. Delay disease transmission and outbreak peak 2. Decompress peak burden on healthcare infrastructure 3. Diminish overall cases and health impacts Daily Cases #1 #2 #3 Days since First Case Pandemic outbreak: No intervention Pandemic outbreak: With intervention
    15. 15. Cough etiquette • Respiratory etiquette – Cover nose / mouth when coughing or sneezing • Hand washing!
    16. 16. Voluntary Isolation • Separation and restricted movement of ill persons with contagious disease (often in a hospital setting and Primarily individual level) – Isolate severe and mild cases – Location of isolation (home, hospital) depends on several factors (severity of illness, the number of affected persons, the domestic setting) – Do not wait for lab confirmation – Plan for large number of severe cases – Provide medical and social care
    17. 17. Voluntary Quarantine • Separation and restricted movement of well persons presumed exposed – Identification of contacts • Often at home, but may be designated residential facility or hospital • Applied at the individual or community level • Regular health monitoring is essential part of quarantine
    18. 18. Hand Washing Method • Wet hands with clean (not hot) water • Apply soap • Rub hands together for at least 20 seconds • Rinse with clean water • Dry with disposable towel or air dry • Use towel to turn off faucet
    19. 19. Alcohol-based Hand Rubs • Effective if hands not visibly soiled • More costly than soap & water Method • Apply appropriate (3ml) amount to palms • Rub hands together, covering all surfaces until dry
    20. 20. Patients Cared for at Home • Potential for transmission • Must educate family caregivers • Fever / symptom monitoring • Infection control measures – Hand washing – Use of available material as mask …
    21. 21. Isolation Precautions
    22. 22. Source: Rosie Sokas, MD MOH UIL at Chicago Droplet precautions: SurgicalDroplet precautions: Surgical MasksMasks
    23. 23. N-95 Filtering Masks
    24. 24. Personal Protective Equipment (PPE)
    25. 25. Antivirals- Oseltamivir • Treatment is 75 mg twice a day for 5 days. • Prophylaxis is 75 mg once a day for 7 days after last exposure. • Prophylaxis: – High risk exposure (household contacts) – Moderate risk (unprotected very close exposure to sick animals; HCW with unprotected exposure to patients) – Low risk exposure: no need for prophylaxis unless activation of exceptional measures.
    26. 26. Importance of the Early Treatment
    27. 27. Thank you